Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Disruption of B-cell homeostatic control mediated by the BLV-Tax oncoprotein: association with the upregulation of Bcl-2 and signaling through NF-κB

Abstract

Transactivating proteins associated with complex onco-retroviruses including human T-cell leukemia virus-1 (HTLV-1) and bovine leukemia virus (BLV) mediate transformation using poorly understood mechanisms. To gain insight into the processes that govern tumor onset and progression, we have examined the impact of BLV-Tax expression on ovine B-cells, the targets of BLV in experimentally infected sheep, using B-cell clones that are dependent on CD154 and γc-common cytokines. Tax was capable of mediating progression of B-cells from cytokine dependence to cytokine independence, indicating that the transactivator can over-ride signaling pathways typically controlled by cytokine receptor activation in B-cells. When examined in the presence of both CD154 and interleukin-4, Tax had a clear supportive role on B-cell growth, with an impact on B-cell proliferation, cell cycle phase distribution, and survival. Apoptotic B-cell death mediated by growth factor withdrawal, physical insult, and NF-κB inhibition was dramatically reduced in the presence of Tax. Furthermore, the expression of Tax was associated with higher Bcl-2 protein levels, providing rationale for the rescue signals mediated by the transactivator. Finally, Tax expression in B-cells led to a dramatic increase of nuclear RelB/p50 and p50/p50 NF-κB dimers, indicating that cellular signaling through NF-κB is a major contributory mechanism in the disruption of B-cell homeostasis. Although Tax is involved in aspects of pathogenesis that are unique to complex retroviruses, the viral strategies associated with this transactivating oncoprotein may have wide-ranging effects that are relevant to other B-cell malignancies.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  • Akagi T, Ono H, Nyunoya H and Shimotohno K . (1997). Oncogene, 14, 2071–2078.

  • Badran BM, Wolinsky SM, Burny A and Willard-Gallo KE . (2002). J. Biol. Chem, 277, 47136–47148.

  • Bagnis C, Chischportich C, Imbert AM, Van den Broeke A, Cornet V and Mannoni P . (1997). Cancer Gene Ther., 4, 5–8.

  • Ballard DW, Bohnlein E, Lowenthal JW, Wano Y, Franza BR and Greene WC . (1988). Science, 241, 1652–1655.

  • Brady J, Jeang KT, Duvall J and Khoury G . (1987). J. Virol., 61, 2175–2181.

  • Brauweiler A, Garrus JE, Reed JC and Nyborg JK . (1997). Virology., 231, 135–140.

  • Burny A, Willems L, Callebaut I, Adam E, Cludts I, Dequiedt F, Droogmans L, Grimonpont C, Kerkhofs P, Mammerickx M, Portetelle D, Van den Broeke A and Kettmann R . (1994). Viruses and Cancer. Minson AC, Neil JC and McRae MA (eds). Cambridge University Press: Cambridge, pp. 213–234.

    Google Scholar 

  • Cahir-McFarland ED, Davidson DM, Schauer SL, Duong J and Kieff E . (2000). Proc. Natl. Acad. Sci. USA, 97, 6055–6060.

  • Carrasco D, Ryseck RP and Bravo R . (1993). Development., 118, 1221–1231.

  • Clark E, Santiago F, Deng L, Chong S, de La FC, Wang L, Fu P, Stein D, Denny T, Lanka V, Mozafari F, Okamoto T and Kashanchi F . (2000). J. Virol., 74, 5040–5052.

  • Cross SL, Feinberg MB, Wolf JB, Holbrook NJ, Wong-Staal F and Leonard WJ . (1987). Cell., 49, 47–56.

  • Derse D . (1987). J. Virol., 61, 2462–2471.

  • Feinman R, Koury J, Thames M, Barlogie B, Epstein J and Siegel DS . (1999). Blood, 93, 3044–3052.

  • Felber BK, Derse D, Athanassopoulos A, Campbell M and Pavlakis GN . (1989). N. Biol., 1, 318–328.

  • Franchini G . (1995). Blood., 86, 3619–3639.

  • Fujii M, Niki T, Mori T, Matsuda T, Matsui M, Nomura N and Seiki M . (1991). Oncogene., 6, 1023–1029.

  • Fujii M, Sassone-Corsi P and Verma IM . (1988). Proc. Natl. Acad. Sci. USA, 85, 8526–8530.

  • Grassmann R, Berchtold S, Radant I, Alt M, Fleckenstein B, Sodroski JG, Haseltine WA and Ramstedt U . (1992). J. Virol., 66, 4570–4575.

  • Griebel P, Beskorwayne T, Godson DL, Popowych Y and Hein W . (2000). J. Immunol. Methods, 237, 19–28.

  • Griebel P, Beskorwayne T, Van den Broeke A and Ferrari G . (1999). Int. Immunol., 11, 1139–1147.

  • Haas L, Divers T and Casey JW . (1992). J. Virol., 66, 6223–6225.

  • Haury M, Freitas A, Hermitte V, Coutinho A and Hibner U . (1993). Oncogene, 8, 1257–1262.

  • Heissmeyer V, Krappmann D, Wulczyn FG and Scheidereit C . (1999). EMBO J., 18, 4766–4778.

  • Horwitz BH, Zelazowski P, Shen Y, Wolcott KM, Scott ML, Baltimore D and Snapper CM . (1999). J. Immunol., 162, 1941–1946.

  • Jeang KT . (2001). Cytokine Growth Factor Rev., 12, 207–217.

  • Jeang KT, Widen SG, Semmes OJ and Wilson SH . (1990). Science, 247, 1082–1084.

  • Kawakami A, Nakashima T, Sakai H, Urayama S, Yamasaki S, Hida A, Tsuboi M, Nakamura H, Ida H, Migita K, Kawabe Y and Eguchi K . (1999). Blood, 94, 3847–3854.

  • Keller SA, Schattner EJ and Cesarman E . (2000). Blood, 96, 2537–2542.

  • Kerkhofs P, Heremans H, Burny A, Kettmann R and Willems L . (1998). J. Virol., 72, 2554–2559.

  • Kettmann R, Burny A, Callebaut I, Droogmans L, Mammerickx M, Willems L and Portetelle D . (1994). The Retroviridae. Levy JA (ed). Plemum Press: New York, pp. 39–81.

    Book  Google Scholar 

  • Kirshenbaum LA . (2000). Clin. Invest. Med., 23, 322–330.

  • Kistler B, Relink A, Marienfeld R, Neumann M and Wirth T . (1998). J. Immunol., 160, 2308–2317.

  • Krappmann D, Patke A, Heissmeyer V and Scheidereit C . (2001). Mol. Cell. Biol., 21, 6640–6650.

  • Kurland JF, Kodym R, Story MD, Spurgers KB, McDonnell TJ and Meyn RE . (2001). J Biol. Chem., 276, 45380–45386.

  • Lee HH, Dadgostar H, Cheng Q, Shu J and Cheng G . (1999). Proc. Natl. Acad. Sci. USA, 96, 9136–9141.

  • Liu YJ, Mason DY, Johnson GD, Abbot S, Gregory CD, Hardie DL, Gordon J and MacLennan IC . (1991). Eur. J. Immunol., 21, 1905–1910.

  • Mammerickx M, Palm R, Portetelle D and Burny A . (1988). Leukemia, 2, 103–107.

  • Mori N, Fujii M, Cheng G, Ikeda S, Yamasaki Y, Yamada Y, Tomonaga M and Yamamoto N . (2001). Virus Genes, 22, 279–287.

  • Motyka B and Reynolds JD . (1995). Immunology, 84, 383–387.

  • Murakami K, Aida Y, Kageyama R, Numakunai S, Ohshima K, Okada K and Ikawa Y . (1994). Am. J. Vet. Res., 55, 72–80.

  • Natarajan K, Singh S, Burke Jr TR, Grunberger D and Aggarwal BB . (1996). Proc. Natl. Acad. Sci. USA, 93, 9090–9095.

  • Neuveut C, Low KG, Maldarelli F, Schmitt I, Majone F, Grassmann R and Jeang KT . (1998). Mol. Cell. Biol., 18, 3620–3632.

  • Pise-Masison CA, Mahieux R, Jiang H, Ashcroft M, Radonovich M, Duvall J, Guillerm C and Brady JN . (2000). Mol. Cell. Biol., 20, 3377–3386.

  • Porter LA, Singh G and Lee JM . (2000). Blood, 95, 2645–2650.

  • Pozzatti R, Vogel J and Jay G . (1990). Mol. Cell. Biol., 10, 413–417.

  • Reyes RA and Cockerell L . (1998). Virology, 242, 184–192.

  • Richardson H, Hollsberg P, Windhagen A, Child LA, Hafler DA and Lever AM . (1997). Blood, 89, 3303–3314.

  • Rovnak J and Casey JW . (1999). J. Virol., 73, 8890–8897.

  • Sagata N, Yasunaga T, Tsuzuku-Kawamura J, Ohishi K, Ogawa Y and Ikawa Y . (1985). Proc. Natl. Acad. Sci. USA, 82, 677–681.

  • Santiago F, Clark E, Chong S, Molina C, Mozafari F, Mahieux R, Fujii M, Azimi N and Kashanchi F . (1999). J. Virol., 73, 9917–9927.

  • Schmitt I, Rosin O, Rohwer P, Gossen M and Grassmann R . (1998). J. Virol., 72, 633–640.

  • Schwartz-Cornil I, Chevallier N, Belloc C, Le Rhun D, Laine V, Berthelemy M, Mateo A and Levy D . (1997). J. Gen. Virol., 78, 153–162.

  • Semmes OJ, Barret JF, Dang CV and Jeang KT . (1996). J. Biol. Chem., 271, 9730–9738.

  • Solan NJ, Miyoshi H, Carmona EM, Bren GD and Paya CV . (2002). J. Biol. Chem., 277, 1405–1418.

  • Stone DM, Norton LK and Davis WC . (2000). J. Gen. Virol., 81, 971–981.

  • Sun SC and Ballard DW . (1999). Oncogene, 18, 6948–6958.

  • Suzuki T, Kitao S, Matsushime H and Yoshida M . (1996). EMBO J., 15, 1607–1614.

  • Tsuchiya H, Fujii M, Niki T, Tokuhara M, Matsui M and Seiki M . (1993). J. Virol., 67, 7001–7007.

  • Twizere JC, Kerkhofs P, Burny A, Portetelle D, Kettmann R and Willems L . (2000). J. Virol., 74, 9895–9902.

  • Van den Broeke A, Bagnis C, Ciesiolka M, Cleuter Y, Gelderblom H, Kerkhofs P, Griebel P, Mannoni P and Burny A . (1999). J. Virol., 73, 1054–1065.

  • Van den Broeke A, Cleuter Y, Beskorwayne T, Kerkhofs P, Szynal M, Bagnis C, Burny A and Griebel P . (2001). J. Virol., 75, 1095–1103.

  • Van den Broeke A, Cleuter Y, Chen G, Portetelle D, Mammerickx M, Zagury D, Fouchard M, Coulombel L, Kettmann R and Burny A . (1989). Proc. Natl. Acad. Sci. USA, 85, 9263–9267.

  • Van den Broeke A, Cleuter Y, Droogmans L, Burny A and Kettmann R . (1997). Immunological Methods Manual. In Vitro Techniques in Experimental Immunology in Sheep. Lefkovits I (ed). Academic Press: London, pp. 2127–2132.

    Google Scholar 

  • Van Kooten C and Banchereau J . (2000). J. Leukoc. Biol., 67, 2–17.

  • Vernau W, Jacobs RM, Valli VE and Heeney JL . (1997). Vet. Pathol., 34, 222–225.

  • Wagner EF, Hleb M, Hanna N and Sharma S . (1998). J. Immunol., 161, 1123–1131.

  • Warren WD, Roberts KL, Linehan LA and Berton MT . (1999). Mol. Immunol., 36, 31–44.

  • Watanabe T . (1997). Int. J. Hematol., 66, 257–278.

  • Weih DS, Yilmaz ZB and Weih F . (2001). J. Immunol., 167, 1909–1919.

  • Wick KR and Berton MT . (2000). Mol. Immunol., 37, 641–652.

  • Willems L, Gegonne A, Chen G, Burny A, Kettmann R and Ghysdael J . (1987). EMBO J., 6, 3385–3389.

  • Willems L, Heremans H, Chen G, Portetelle D, Billiau A, Burny A and Kettmann R . (1990). EMBO J., 9, 1577–1581.

  • Willems L, Kerkhofs P, Dequiedt F, Portetelle D, Mammerickx M, Burny A and KettmannR . (1994). Proc. Natl. Acad. Sci. USA, 91, 11532–11536.

  • Willems L, Kettmann R, Dequiedt F, Portetelle D, Voneche V, Cornil I, Kerkhofs P, Burny A and Mammerickx M . (1993). J. Virol., 67, 4078–4085.

  • Wu M, Lee H, Bellas RE, Schauer SL, Arsura M, Katz D, FitzGerald MJ, Rothstein TL, Sherr DH and Sonenshein GE . (1996). EMBO J., 15, 4682–4690.

Download references

Acknowledgements

We thank Troy Randall for the generous gift of mCD154 L cells and Daniel Portetelle for providing the anti-Tax antibodies. This work was supported by funds from the F.N.R.S., the Fonds Medic, the Fondation Bekales, the G.V.P.N., the A.F.M., and the C.I.H.R. MS is supported by an F.R.I.A. F.N.R.S. grant and CVL is Maître de Recherches of the F.N.R.S.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Anne Van den Broeke.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Szynal, M., Cleuter, Y., Beskorwayne, T. et al. Disruption of B-cell homeostatic control mediated by the BLV-Tax oncoprotein: association with the upregulation of Bcl-2 and signaling through NF-κB. Oncogene 22, 4531–4542 (2003). https://doi.org/10.1038/sj.onc.1206546

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1206546

Keywords

This article is cited by

Search

Quick links